GDM Therapy Development Service

GDM Therapy Development Service

Treatment of gestational diabetes mellitus (GDM) aims to reverse hyperglycemia and reduce the risk of the associated adverse pregnancy outcomes. At the same time, pay attention to the safety of the therapy for mother and baby. Ace Therapeutics can provide researchers engaged in therapy development of GDM with more efficient function analysis and overall therapy services.

Overview of GDM

GDM is characterized by the inability of pancreatic β-cells to respond adequately to the increased insulin requirements of pregnancy resulting in varying degrees of hyperglycemia. Many risk factors for developing GDM are similar to those for type 2 diabetes, including obesity, family history of diabetes, and high-risk ethnicities. Additional risk factors include increased maternal age, fetal macrosomia, and personal history of GDM.

Fig 2. Organs Involved in The Pathophysiology of GDMOrgans Involved in The Pathophysiology of GDM (Jasmine, F. A.; et al. International Journal of Molecular Sciences. 2018)

Therapies of GDM

Gestational diabetes is treated with a diabetic diet, exercise, medication (such as metformin), and sometimes insulin therapy. Management of GDM should occur in a multidisciplinary setting with joint diabetes and obstetric input. Most women can manage their GDM with dietary changes and exercise.

  • Pharmacological Therapy
    If blood glucose targets are not achieved with lifestyle intervention, the addition of glucose-lowering therapy is warranted. The pharmacological therapy mainly includes multiple daily insulin injections, oral metformin and glyburide (the only oral agents used in the treatment of GDM), and some safe insulin analogs (rapid and long acting) during pregnancy.

Our Services

Therapy research provides more options for gestational diabetes treatment options. With the goal of scientific research of GDM, Ace Therapeutics can provide the therapy development services such as antidiabetics development (including insulin analog) and safety validation for gestational diabetes mellitus. Our services include but not limited to the followings.

Fig 3. Insulin AnalogsInsulin Analogs
Fig 4. Oral AgentsOral Agents
The rapid-acting insulin analogs and long-acting insulin analogs are effective in the treatment of GDM, but their safety has been controversial.
Ace Therapeutics offers a full range of services for insulin analogs development, from target identification to drug optimization, providing in vitro and in vivo research assays.
With the exception of metformin and glyburide, many oral agents that can be used for T2DM have not been fully validated in GDM.
Ace Therapeutics offers a complete package of drugs development and safety validation services for oral agents of GDM to accelerate your drug development process.

Features of Our Services

Highly CustomizableHighly Customizable

One-stop ServicesOne-stop Services

High QualityHigh Quality

Professional TeamProfessional Team

Ace Therapeutics offers cost-effect and high-quality research services related to gestational diabetes mellitus therapy for our clients worldwide. Our assays are developed and processed with the highest standard and the results are delivered on time without compromising quality. Please feel free to contact us .


  1. Emma, C. J.; et al. Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications. Trends in Endocrinology & Metabolism. 2018, 29(11), 743-754.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Services
Related Products
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.